Practical Synthesis of 7-Bromo-4-chloro-1 H -indazol-3-amine: An Important Intermediate to Lenacapavir.
Naeem AsadMichael LyonsShirley Muniz Machado RodriguesJustina M BurnsThomas D RoperG Michael LaidlawSaeed AhmadB Frank GuptonDouglas KlumppLi-Mei JinPublished in: Molecules (Basel, Switzerland) (2024)
7-Bromo-4-chloro-1 H -indazol-3-amine is a heterocyclic fragment used in the synthesis of Lenacapavir, a potent capsid inhibitor for the treatment of HIV-1 infections. In this manuscript, we describe a new approach to synthesizing 7-bromo-4-chloro-1 H -indazol-3-amine from inexpensive 2,6-dichlorobenzonitrile. This synthetic method utilizes a two-step sequence including regioselective bromination and heterocycle formation with hydrazine to give the desired product in an overall isolated yield of 38-45%. The new protocol has been successfully demonstrated on hundred-gram scales without the need for column chromatography purification. This new synthesis provides a potential economical route to the large-scale production of this heterocyclic fragment of Lenacapavir.
Keyphrases
- randomized controlled trial
- mass spectrometry
- hiv infected
- liquid chromatography
- hepatitis c virus
- antiretroviral therapy
- human immunodeficiency virus
- hiv testing
- hiv aids
- tandem mass spectrometry
- high speed
- human health
- high resolution
- men who have sex with men
- south africa
- combination therapy
- solid phase extraction
- simultaneous determination